A Long Term Safety Study With Atrasentan
NCT00127478
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
166
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Adenocarcinoma
Interventions
DRUG:
Atrasentan
Sponsor
Abbott